Yetimler, Berrak

Profile URL
https://hdl.handle.net/20.500.12573/2828
Name Variants
Berrak Yetimler
Job Title
Dr. Öğr. Üyesi
Email Address
berrak.yetimler@agu.edu.tr
Main Affiliation
04.02. Moleküler Biyoloji ve Genetik
Status
Current Staff
Website
ORCID ID
0000-0003-2807-4194
Scopus Author ID
55342957000
Turkish CoHE Profile ID
741F54449CDC13D5
Google Scholar ID
kEHkReQAAAAJ&hl
WoS Researcher ID
LZE-2698-2025
No research topics data found.

Sustainable Development Goals

SDG data is not available
Documents

6

Citations

146

h-index

5

Go to Scopus profile
Documents

8

Citations

140

Go to WoS profile
No records found in other affiliations.
Scholarly Output

1

Articles

1

Views / Downloads

0/0

Supervised MSc Theses

0

Supervised PhD Theses

0

WoS Citation Count

0

Scopus Citation Count

0

Patents

0

Projects

0

WoS Citations per Publication

0.00

Scopus Citations per Publication

0.00

Open Access Source

1

Supervised Theses

0

Journals data is not available

Scopus Quartile Distribution

Quartile distribution chart data is not available

Competency Cloud

GCRIS Competency Cloud

Filters

20261

Settings

Author of Publication: search.filters.isAuthorOfPublication.3ba8952f-5fe0-4ae3-816f-2c46f14cd3e9

Scholarly Output Search Results

Now showing 1 - 1 of 1
  • Article
    Immune-Driven Mechanisms in Idiopathic Intracranial Hypertension: A Critical Synthesis
    (Walter de Gruyter GmbH, 2026) Tuzun, Erdem; Yetimler, Berrak
    Idiopathic intracranial hypertension (IIH) is increasingly recognised as a complex disorder characterized by elevated intracranial pressure (ICP), with evidence suggesting contributions from dysregulated cerebrospinal fluid (CSF) dynamics as well as metabolic, endocrine, and neurovascular mechanisms. IIH predominantly affects women of reproductive age who are living with obesity. Clinically, IIH may be asymptomatic or present with severe headaches, visual disturbances, and papilledema, with a risk of visual impairment in some untreated or refractory cases. Although the etiopathogenesis of IIH remains unclear, emerging evidence from metabolic and immunological studies suggests that immune-mediated mechanisms may contribute to disease pathophysiology. In this review, we synthesize current literature on the potential contribution of the immune system to IIH, integrating findings across obesity-associated inflammation, circulating cytokine profiles, comorbid inflammatory and autoimmune conditions, and markers of neuroglial stress and injury. We summarize converging data suggesting that IIH may, at least in part, be influenced by a pro-inflammatory milieu that affects CSF dynamics. While available studies highlight intriguing immunological signals, the underlying mechanistic pathways remain poorly resolved. Larger, longitudinal, and mechanistically grounded investigations are needed to clarify causality, identify relevant immune subtypes, and determine whether immune modulation may offer therapeutic opportunities in IIH.